Health Care/Hospital

Linkwell Corporation Announces 2006 Year End Financial Results, Record Revenues and Net Income

SHANGHAI, China, April 4 /Xinhua-PRNewswire/ -- Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, today announced its financial results for the year ended December 31, 2006. The Company rec...

2007-08-09 13:51 769

China Biopharmaceuticals Holdings Announces Fiscal Year 2006 Financial Results

BEIJING, April 3 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdings, Inc. (OTC Bulletin Board: CHBP), a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, today announced its financial results for the yea...

2007-04-04 11:00 837

3SBio Inc. Announces Fourth Quarter And Fiscal Year 2006 Results

- Q4 2006 net revenues grew 36.0%, as compared to Q4 2005, to US$4.5 million - Q4 2006 operating income up 148.1%, as compared to Q4 2005, to US$1.1 million - 2006 fiscal year net revenues increased 25.3% year-over-year to US$16.4 million - 20...

2007-04-03 04:30 877

Message from Dr Henk Bekedam, WHO Representative in China

World Health Day: International Health Security - 7 April 2007 BEIJING, April 2 /Xinhua-PRNewswire/ -- This year's World Health Day theme is an important reminder that many health threats do not respect national borders and that all countries are partners in the fight for international hea...

2007-04-02 13:00 785

China Pharma Holdings, Inc. Announces Record Fourth Quarter and 2006 Year End Results

HAIKOU CITY, Hainan, China, March 29 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), a specialty bio-pharmaceutical company that develops, manufactures and markets Western and Chinese medicines, today announced its financial results...

2007-03-29 19:50 913

Cyprotex Extends Cloe(R) Screen Mechanism-Based Inhibition Service to Include 4 Additional Cytochrome P450 Isoforms

MANCHESTER, England, March 29 /Xinhua-PRNewswire/ -- Today, Cyprotex announces that it has enhanced its Cloe(R) Screen Mechanism-Based Inhibition service to include 4 additional cytochrome P450 (CYP450) isoforms. These new assays complement the CYP3A4 isoform assay which was launched last year...

2007-03-29 14:00 832

CCID Consulting Reviews China's Medical Insurance Information System

BEIJING, March 28 /Xinhua-PRNewswire/ -- CCID Consulting, China's leading research, consulting and IT outsourcing service provider, the first Chinese consulting firm listed in Hong Kong, published its review on China's medical insurance information system today. Currently, medical insur...

2007-03-28 20:00 1103

Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

Oral Agent Designed to Address High Incidence of Relapse in DLBCL Population INDIANAPOLIS, March 27 /Xinhua-PRNewswire/ -- Eli Lilly and Company announced to-day that the European Medicines Agency (EMEA) has granted enzastaurin, an in-vestigational, multi-targeted, oral, cancer agent, orpha...

2007-03-27 08:39 774

WuXi PharmaTech Installs Supercritical Fluid Chromatography System

SHANGHAI, China, March 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has purchased and successfully brought online a Berger Supercritical Fluid Chromatography (SFC) MultiGram(R)III preparative system. ...

2007-03-26 21:53 1538

China Pharma Holdings, Inc. Announces Conference Call to Discuss Fourth Quarter and Year-End 2006 Results

HAIKOU CITY, Hainan Province, China, March 26 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) today announced that the Company will host a conference call at 09:00 am EST on Thursday, March 29, 2007, to discuss results for the fourth quart...

2007-03-26 20:00 765

World Stop TB Day - 24 March 2007

Message From Dr Henk Bekedam, WHO Representative in China BEIJING, March 23 /Xinhua-PRNewswire/ -- World Stop Tuberculosis (TB) Day is an important occasion and this year's theme - Drug-resistant TB: Treat it. Prevent it - is a vital reminder of the challenges that remain in China's fight ...

2007-03-23 15:59 699

Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership

Funding enables partnership to continue critical battle against MDR-TB; Reinvestment brings Lilly's total commitment to $120 million for long-term, sustainable program NEW YORK, March 22 /Xinhua-PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to invest an additional $...

2007-03-22 12:01 803

Potentia Pharmaceuticals Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration

-- POT-4 is the First Complement Inhibitor for Age-related Macular Degeneration to Enter Clinical Phase of Development LOUISVILLE, Ky., March 20 /Xinhua-PRNewswire/ -- Potentia Pharmaceuticals, Inc. announced today that it is entering the clinical phase of development for POT-4, its...

2007-03-20 16:00 797

REACH Registry Demonstrates That Multiple Arterial Disease Locations Sharply Increase the Risk of Major CV Events in Outpatients With Atherothrombosis

The Reduction of Atherothrombosis for Continued Health (REACH) Registry 1-Year Results PARIS, March 20 /Xinhua-PRNewswire/ -- The REACH Registry 1-year results paper published today in the Journal of the American Medical Association (JAMA) show that outpatients with atherothrombosis have a s...

2007-03-20 22:00 826

SEROQUEL(R) Sustained Release Schizophrenia Data Presented at ECP Congress in Madrid

LONDON, March 19 /Xinhua-PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release) clinical trial data presented at the European Congress of Psychiatry (ECP) in Madrid. The data demonstrated that the SEROQUEL(R) ...

2007-03-19 09:02 761

Pharmaxis Reports Phase II Results for Aridol in COPD

SYDNEY, Australia, March 14 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the results from its Phase II trial for Aridol in subjects with Chronic Obstructive Pulmonary Disease (COPD), a respiratory disease affecting over 30 million p...

2007-03-14 21:00 661

Mindray Medical International Announces Fourth Quarter and Full Year 2006 Results

Rapid International Expansion Drives Record Revenues Company Ends Year with Strong Debt-free Balance Sheet; Declares Cash Dividend of US$0.15 Per Share SHENZHEN, China, March 12 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR) today announced its selecte...

2007-03-12 20:13 752

Protection From Osteoporosis - Bone is Living Tissue

Protection From Osteoporosis - Bone is Living Tissue BASEL, Switzerland, March. 8 /Xinhua-PRNewswire/ -- In Europe, a bone breaks every 30 seconds due to osteoporosis. Each year, nearly 1.5 million Americans over 50 suffer fractures caused by this bone disease. Bone is a living tis...

2007-03-08 12:17 846

China Biopharmaceuticals Holdings' Subsidiary Enshi Pharmaceuticals Wins Two Industry Awards

Our Hepatitis drug, Ganbifu, Named as One of China's 2006 "Top Ten Most Popular Hepatic Drugs" Enshi's General Manager, Peixiang Cong, Honored as One of China's 2006 "Outstanding Managers for Brand Promotion" BEIJING, March 7 /Xinhua-PRNewswire-FirstCall/ -- China Biopharmaceuticals Holdin...

2007-03-07 22:00 679

China Sky One Medical Announces Three New Diagnostic Kits Have Passed National Final Inspection

HARBIN, China, March 6 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI), one of the leading producers and distributors for external-Chinese medicine in China, has announced that the AMI Diagnostic Kit, Human Urinary Albumin Elisa Kit and Early Pregnancy...

2007-03-06 21:00 778
1 ... 523524525526527528529 ... 532